- Acoramidis treatment led to a highly significant reduction in all-cause mortality (ACM) and recurrent cardiovascular-related hospitalizations (CVH) at Month 30 compared with placebo - Additionally, ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Risk for AF recurrence was increased in patients who ...

Please provide your email address to receive an email when new articles are posted on . Registry data from Finland show a rapid increase of recurrent CV events and deaths within the first 6 months of ...

- An early and sustained improvement relative to placebo in time to first event (CVH or ACM) with a separation of event rates starting at Month 3 - A 42% reduction in composite ACM and recurrent CVH ...

New York, New York--(Newsfile Corp. - October 22, 2025) - OS Therapies Inc. (OSTX) ("OS Therapies" or "the Company"), a clinical-stage cancer immunotherapy and antibody drug conjugate biotechnology ...

Background: Although Campylobacter is the leading cause of reported bacterial gastro-enteritis in industrialized countries, little is known on its recurrence. The objective of this study is to ...

Recurrent arrhythmia, where irregular heart rhythms return even after treatment, can present challenges and increase the risk of complications, but can be managed with a cardiologist’s help and ...